SWOG Is (I Am) Thankful for a New Committee Co-Chair, and Much More
This Thanksgiving, I want to express my gratitude for your dedication to our patients and to SWOG's mission of significantly improving lives through cancer trials and translational research. Your work and commitment are both humbling and inspiring.
I’m also grateful to be able to announce that Dr. Jason Zell is the new co-chair of our prevention, screening, and surveillance committee, leading alongside continuing co-chair Dr. Banu Arun. He takes the spot vacated by Dr. Marian Neuhouser, who stepped down as committee co-chair at our fall group meeting.
Dr. Zell is known to many of you as principal investigator of our S0820 PACES study, testing whether the combination of eflornithine and sulindac can reduce the rate of high-risk adenomas and second cancers in patients previously treated for colorectal cancer. This phase III study closed to accrual last year and is now in follow-up.
A graduate of SWOG’s Early Stage Investigator Training Course, and a past Coltman Fellow, Dr. Zell has also served on The Hope Foundation’s board of directors and in numerous other leadership roles within SWOG, the NCI, and his home institution of the University of California – Irvine.
He is an outstanding choice for partnering with Dr. Arun to lead our prevention, screening, and surveillance committee, and I thank the search committee for their work in ensuring SWOG’s research in this area will continue in great hands.
Have a wonderful Thanksgiving Day weekend!
Other Recent Stories
